We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Swissmedic Rolls Out First Changes to Drug Authorization Process
Swissmedic Rolls Out First Changes to Drug Authorization Process
Swissmedic is revising its drug approval process to streamline authorizations for certain products. The overhaul will take place in several phases, beginning in early 2018. The first revisions will address pediatric drug dosage recommendations.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor